Year |
Citation |
Score |
2023 |
Su MC, Nethi SK, Dhanyamraju PK, Prabha S. Nanomedicine Strategies for Targeting Tumor Stroma. Cancers. 15. PMID 37627173 DOI: 10.3390/cancers15164145 |
0.312 |
|
2023 |
Nethi SK, Li X, Bhatnagar S, Prabha S. Enhancing Anticancer Efficacy of Chemotherapeutics Using Targeting Ligand-Functionalized Synthetic Antigen Receptor-Mesenchymal Stem Cells. Pharmaceutics. 15. PMID 37376189 DOI: 10.3390/pharmaceutics15061742 |
0.32 |
|
2023 |
Prabha S, Merali C, Sehgal D, Nicolas E, Bhaskar N, Flores M, Bhatnagar S, Nethi SK, Barrero CA, Merali S, Panyam J. Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing. Materials Today. Bio. 19: 100567. PMID 36747581 DOI: 10.1016/j.mtbio.2023.100567 |
0.623 |
|
2022 |
Bhatnagar S, Revuri V, Shah M, Larson P, Shao Z, Yu D, Prabha S, Griffith TS, Ferguson D, Panyam J. Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers. 14. PMID 36551577 DOI: 10.3390/cancers14246091 |
0.528 |
|
2021 |
Cheng S, Nethi SK, Al-Kofahi M, Prabha S. Pharmacokinetic-Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells. Pharmaceutics. 13. PMID 33445681 DOI: 10.3390/pharmaceutics13010092 |
0.355 |
|
2020 |
Cao J, Bhatnagar S, Wang J, Qi X, Prabha S, Panyam J. Cancer stem cells and strategies for targeted drug delivery. Drug Delivery and Translational Research. PMID 33095384 DOI: 10.1007/s13346-020-00863-9 |
0.62 |
|
2020 |
Layek B, Shetty M, Nethi SK, Sehgal D, Starr TK, Prabha S. Mesenchymal Stem Cells As Guideposts for Nanoparticle-Mediated Targeted Drug Delivery in Ovarian Cancer. Cancers. 12. PMID 32295145 DOI: 10.3390/cancers12040965 |
0.479 |
|
2019 |
Cheng S, Nethi SK, Rathi S, Layek B, Prabha S. Engineered Mesenchymal Stem Cells (MSCs) for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy. The Journal of Pharmacology and Experimental Therapeutics. PMID 31175219 DOI: 10.1124/Jpet.119.259796 |
0.482 |
|
2019 |
Moku G, Layek B, Trautman L, Putnam S, Panyam J, Prabha S. Improving Payload Capacity and Anti-Tumor Efficacy of Mesenchymal Stem Cells Using TAT Peptide Functionalized Polymeric Nanoparticles. Cancers. 11. PMID 30959908 DOI: 10.3390/Cancers11040491 |
0.739 |
|
2019 |
Prabha S, Moku G, Layek B, Panyam J. Abstract 3623: Mesenchymal stem cells engineered with TAT peptide functionalized nanoparticles improve therapeutic efficacy of paclitaxel in an orthotopic lung tumor model Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3623 |
0.673 |
|
2019 |
Layek B, Sehgal D, Panyam J, Prabha S. Abstract 987: Glycoengineered MSCs for targeting platinum resistant ovarian tumors Cancer Research. 79: 987-987. DOI: 10.1158/1538-7445.Am2019-987 |
0.702 |
|
2019 |
Nethi SK, Sehgal D, Cheng S, Panyam J, Prabha S. Abstract 2175: Synthetic antigen receptor mesenchymal stem cells (SAR-MSCs) targeting perlecan for drug delivery to ovarian cancer Cancer Research. 79: 2175-2175. DOI: 10.1158/1538-7445.Am2019-2175 |
0.65 |
|
2019 |
Layek B, Sehgal D, Argenta PA, Panyam J, Prabha S. Nanoengineering of Mesenchymal Stem Cells via Surface Modification for Efficient Cancer Therapy Advanced Therapeutics. 2: 1900043. DOI: 10.1002/ADTP.201900043 |
0.554 |
|
2018 |
Layek B, Sadhukha T, Panyam J, Prabha S. Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting. Molecular Cancer Therapeutics. PMID 29592881 DOI: 10.1158/1535-7163.Mct-17-0682 |
0.696 |
|
2018 |
Layek B, Panyam J, Prabha S. Abstract 3723: Nanoengineered mesenchymal stem cells successfully inhibit tumor progression in a syngeneic mouse model Cancer Research. 78: 3723-3723. DOI: 10.1158/1538-7445.Am2018-3723 |
0.713 |
|
2017 |
Sadhukha T, Layek B, Prabha S. Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems. Drug Delivery and Translational Research. PMID 28462499 DOI: 10.1007/S13346-017-0383-6 |
0.357 |
|
2017 |
Prabha S, Sadhukha T, Layek B. Abstract 3103: Nanoengineered mesenchymal stem cells for targeted lung cancer therapy Cancer Research. 77: 3103-3103. DOI: 10.1158/1538-7445.Am2017-3103 |
0.549 |
|
2016 |
Layek B, Sadhukha T, Prabha S. Glycoengineered mesenchymal stem cells as an enabling platform for two-step targeting of solid tumors. Biomaterials. 88: 97-109. PMID 26946263 DOI: 10.1016/J.Biomaterials.2016.02.024 |
0.491 |
|
2016 |
Usacheva M, Layek B, Rahman Nirzhor SS, Prabha S. Nanoparticle-Mediated Photodynamic Therapy for Mixed Biofilms Journal of Nanomaterials. 2016. DOI: 10.1155/2016/4752894 |
0.353 |
|
2015 |
Fernández-Gallardo J, Elie BT, Sadhukha T, Prabha S, Sanaú M, Rotenberg SA, Ramos JW, Contel M. Heterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivo. Chemical Science (Royal Society of Chemistry : 2010). 6: 5269-5283. PMID 27213034 DOI: 10.1039/C5Sc01753J |
0.309 |
|
2014 |
Sadhukha T, O'Brien TD, Prabha S. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 243-51. PMID 25456830 DOI: 10.1016/J.Jconrel.2014.10.015 |
0.546 |
|
2014 |
Frik M, MartÃnez A, Elie BT, Gonzalo O, RamÃrez de Mingo D, Sanaú M, Sánchez-Delgado R, Sadhukha T, Prabha S, Ramos JW, Marzo I, Contel M. In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer. Journal of Medicinal Chemistry. 57: 9995-10012. PMID 25409416 DOI: 10.1021/Jm5012337 |
0.312 |
|
2014 |
Chandra Hembram K, Prabha S, Chandra R, Ahmed B, Nimesh S. Advances in preparation and characterization of chitosan nanoparticles for therapeutics. Artificial Cells, Nanomedicine, and Biotechnology. 44: 305-14. PMID 25137489 DOI: 10.3109/21691401.2014.948548 |
0.415 |
|
2014 |
Prabha S, Arya G, Chandra R, Ahmed B, Nimesh S. Effect of size on biological properties of nanoparticles employed in gene delivery. Artificial Cells, Nanomedicine, and Biotechnology. 44: 83-91. PMID 24866724 DOI: 10.3109/21691401.2014.913054 |
0.424 |
|
2014 |
Sadhukha T, Prabha S. Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin. Aaps Pharmscitech. 15: 1029-38. PMID 24831091 DOI: 10.1208/S12249-014-0139-2 |
0.588 |
|
2014 |
Prabha S, Sadhukha T. Abstract 5420: Nano-engineered mesenchymal stem cells as targeted therapeutic carriers Cancer Research. 74: 5420-5420. DOI: 10.1158/1538-7445.Am2014-5420 |
0.58 |
|
2014 |
Udaya Prakash NK, Bhuvaneswari S, Prabha SB, Kavitha K, Sandhya KV, Sathyabhuvaneshwari P, Bharathiraja B. Green synthesis of silver nanoparticles using airborne actinomycetes International Journal of Chemtech Research. 6: 4123-4127. |
0.354 |
|
2012 |
Prabha S, Sharma B, Labhasetwar V. Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice. Cancer Gene Therapy. 19: 530-7. PMID 22595792 DOI: 10.1038/Cgt.2012.26 |
0.63 |
|
2004 |
Prabha S, Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Molecular Pharmaceutics. 1: 211-9. PMID 15981924 DOI: 10.1021/Mp049970+ |
0.662 |
|
2004 |
Prabha S, Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharmaceutical Research. 21: 354-64. PMID 15032319 DOI: 10.1023/B:Pham.0000016250.56402.99 |
0.639 |
|
2003 |
Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. International Journal of Pharmaceutics. 262: 1-11. PMID 12927382 DOI: 10.1016/S0378-5173(03)00295-3 |
0.728 |
|
2002 |
Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. International Journal of Pharmaceutics. 244: 105-15. PMID 12204570 DOI: 10.1016/S0378-5173(02)00315-0 |
0.723 |
|
2002 |
Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1217-26. PMID 12153989 DOI: 10.1096/Fj.02-0088Com |
0.718 |
|
2002 |
Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release : Official Journal of the Controlled Release Society. 82: 105-14. PMID 12106981 DOI: 10.1016/S0168-3659(02)00127-X |
0.725 |
|
Show low-probability matches. |